Skip to main content
Log in

Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-α on this pathway

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disorder that affects various organs and systems. Increased apoptosis, together with defects in the uptake of apoptotic bodies, are thought to have a pathogenic role in SLE. By detection of chromatin condensation, 30% of apoptosis was detected in peripheral blood mononuclear cells (PBMC) from Thai patients with active SLE. Therefore, understanding of the molecular processes in PBMC apoptosis may allow us to gain insight into pathophysiology of SLE. Thus, genes involved in the apoptosis of PBMC from these patients were investigated ex vivo by cDNA array analysis. Seventeen apoptosis-related genes were stimulated in active SLE, more than twofold higher than in inactive SLE. These genes are classified into six groups, namely death receptors, death ligands, caspases, bcl-family, and neutral proteases and genes involved in endoplasmic reticulum stress-mediated apoptosis, such as caspase-4 and GADD153. Among those stimulated genes, tumor necrosis factor (TNF) and the TNF-receptor family were drastically up-regulated 60- and 19-fold higher than in healthy controls, respectively. Moreover, the degree of apoptosis correlated with the level of TNF-α in plasma, suggesting that the TNF family plays a role in the induction of apoptosis in SLE. To verify this hypothesis, PBMC from healthy individuals were treated with plasma from active SLE patients in the presence or absence of etanercept, a TNF inhibitor. In the presence of etanercept, active SLE plasma reduced the level of apoptosis to 26.43%. In conclusion, massive apoptotic death of PBMC occurred during the active stage of SLE. The molecular pathway of SLE-PBMC apoptosis was mediated at least via TNF/TNFR signaling pathway, which was confirmed by functional test of TNF-α in SLE patients’ plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Manson JJ, Isenberg DA (2003) The pathogenesis of systemic lupus erythematosus. Neth J Med 61:343–346

    PubMed  CAS  Google Scholar 

  2. Hanhn B (2001) Systemic lupus erythematosus. In Brewnwald E (ed) Principles of internal medicine. McGraw-Hill, New York pp 1922–1928

    Google Scholar 

  3. Gordon C, Salmon M (2001) Update on systemic lupus erythematosus: autoantibodies and apoptosis. Clin Med 1:10–14

    PubMed  CAS  Google Scholar 

  4. Jin O, Sun LY, Zhou KX, Zhang XS, Feng XB, Mok MY et al (2005) Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Clin Rheumatol 24:107–110

    Article  PubMed  Google Scholar 

  5. Bijl M, Limburg PC, Kallenberg CG, Borchers A, Ansari AA, Hsu T et al (2001) New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. Neth J Med 59:66–75

    Article  PubMed  CAS  Google Scholar 

  6. Devitt A, Pierce S, Oldreive C, Shingler WH, Gregory CD (2003) CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine. Cell Death Differ 10:371–382

    Article  PubMed  CAS  Google Scholar 

  7. Steinbach F, Henke F, Krause B, Thiele B, Burmester GR, Hiepe F (2000) Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis 59:283–288

    Article  PubMed  CAS  Google Scholar 

  8. Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265–285

    PubMed  CAS  Google Scholar 

  9. Gabler C, Kalden JR, Lorenz HM (2003) The putative role of apoptosis-modified histones for the induction of autoimmunity in systemic lupus erythematosus. Biochem Pharmacol 66:1441–1446

    Article  PubMed  CAS  Google Scholar 

  10. Shono M, Shimizu I, Omoya T, Hiasa A, Honda H, Tomita Y et al (1998) Differences in ethidium bromide and 4’-6-diamidino-2-phenylindole staining profiles with regard to DNA fragmentation during apoptosis. Biochem Mol Biol Int 46:1055–1061

    PubMed  CAS  Google Scholar 

  11. Theerasurakarn S, Ubol S (1998) Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness. J Neurovirol 4: 407–414

    Article  PubMed  CAS  Google Scholar 

  12. Studnicka-Benke A, Steiner G, Petera P, Smolen JS (1996) Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 35:1067–1074

    Article  PubMed  CAS  Google Scholar 

  13. Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22

    Article  PubMed  CAS  Google Scholar 

  14. Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M et al (2001) Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Anticancer Res 21:3053–3059

    PubMed  CAS  Google Scholar 

  15. Amerio P, Frezzolini A, Abeni D, Teofoli P, Girardelli CR, De Pita O et al (2002) Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, proinflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with proinflammatory cytokines. Clin Exp Rheumatol 20:535–538

    PubMed  CAS  Google Scholar 

  16. Sjowall C, Ernerudh J, Bengtsson AA, Sturfelt G, Skogh T (2004) Reduced anti-TNF alpha autoantibody levels coincide with flare in systemic lupus erythematosus. J Autoimmun 22:315–323

    Article  PubMed  CAS  Google Scholar 

  17. Bengtsson AA, Sturfelt G, Gullstrand B, Truedsson L (2004) Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus—an additional mechanism to increased autoantigen load? Clin Exp Immunol 135:535–543

    Article  PubMed  CAS  Google Scholar 

  18. Matsuyama W, Yamamoto M, Higashimoto I, Oonakahara KI, Watanabe M, Machida K et al (2004) TNF related apoptosis inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 104:184–191

    Article  PubMed  CAS  Google Scholar 

  19. Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897

    Article  PubMed  Google Scholar 

  20. Tiefenthaler M, Bacher N, Linert H, Muhlmann O, Hofer S, Sepp N et al (2003) Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus. Lupus 12:471–478

    Article  PubMed  CAS  Google Scholar 

  21. Schultz DR, Harrington WJ Jr (2003) Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 32:345–369

    Article  PubMed  CAS  Google Scholar 

  22. Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT et al (1996) A death-domain-containing receptor that mediates apoptosis. Nature 384:372–375

    Article  PubMed  CAS  Google Scholar 

  23. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK et al (1990) A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331–8335

    Article  PubMed  CAS  Google Scholar 

  24. Pimentel-Muinos FX, Seed B (1999) Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11:783–793

    Article  PubMed  CAS  Google Scholar 

  25. Oyadomari S, Mori M (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11:381–389

    Article  PubMed  CAS  Google Scholar 

  26. Siman R, Flood DG, Thinakaran G, Neumar RW (2001) Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer’s disease-linked presenilin-1 knock-in mutation. J Biol Chem 276:44736–44743

    Article  PubMed  CAS  Google Scholar 

  27. Altznauer F, Conus S, Cavalli A, Folkers G, Simon HU (2004) Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 279:5947–5957

    Article  PubMed  CAS  Google Scholar 

  28. Huang Y, Wang KK, Vanderklish PW, Bahr BA, Kidd VJ, Lahti JM et al (2001) The calpain family and human disease. Trends Mol Med 7:355–362

    Article  PubMed  CAS  Google Scholar 

  29. Vanderklish PW, Bahr BA (2000) The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 81:323–339

    Article  PubMed  CAS  Google Scholar 

  30. Kim MJ, Jo DG, Hong GS, Kim BJ, Lai M, Cho DH et al (2002) Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death. Proc Natl Acad Sci USA 99:9870–9875

    Article  PubMed  CAS  Google Scholar 

  31. Chan SL, Mattson MP (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 58:167–190

    Article  PubMed  CAS  Google Scholar 

  32. Kreuter M, Langer C, Kerkhoff C, Reddanna P, Kania AL, Maddika S et al (2004) Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development. Arch Immunol Ther Exp (Warsz) 52:141–155

    CAS  Google Scholar 

Download references

Acknowledgements

We gratefully thank all the patients and all the medical staffs who generously collaborated with this research. We are grateful to Ms. Oravan Verasertniyom and the staff of the Division of Allergy Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University for providing us the samples. We also thank Prof. Jisnuson Svasti for critical editing of the manuscript. This work is supported by Mahidol University Research Grant (Grant number 02011854-0005) to Yindee Kitiyanant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sukathida Ubol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pitidhammabhorn, D., Kantachuvesiri, S., Totemchokchyakarn, K. et al. Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-α on this pathway. Clin Rheumatol 25, 705–714 (2006). https://doi.org/10.1007/s10067-005-0162-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-0162-5

Keywords

Navigation